Federal award
ANACOR PHARMACEUTICALS, INC.
HDTRA114C0003
Contract
Obligated and Ceiling
- Obligated (net)
- $7,777,952.59
- Ceiling (potential value, not spending)
- $13,644,261.00
- Current value
- $7,909,191.00
- Gross positive obligations
- $7,909,191.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ANACOR PHARMACEUTICALS, INC. · HGNKDH1DLM86
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- PFIZER INC · MHBQULRMEEJ5
- Awarding agency
- Department of War · sub-agency 9763 · office S3309A
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AN92 · R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- HDTRA114C0003
- Award type code
- D
- Actions
- 8 · Oct 16, 2013 to Feb 26, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History8
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 26, 2020 | FY2020 | A00001 | C | −$131,238.41 | — |
| Jun 19, 2018 | FY2018 | ARZ999 | W | $0.00 | — |
| Aug 13, 2015 | FY2015 | P00005 | M | $0.00 | — |
| Mar 31, 2015 | FY2015 | P00004 | M | $0.00 | — |
| Feb 18, 2015 | FY2015 | P00003 | M | $148,934.00 | — |
| Aug 8, 2014 | FY2014 | P00002 | G | $5,003,289.00 | — |
| Nov 8, 2013 | FY2014 | P00001 | M | $0.00 | — |
| Oct 16, 2013 | FY2014 | 0 | — | $2,756,968.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.